These are some of this morning’s top pre-market analyst upgrades and positive research calls from Wall Street this Thursday morning with over two hours until the market opens:

Axsys Technologies (AXYS) Raised to Overweight at JPMorgan.
Crucell (CRXL) Started as Buy at Jefferies.
DuPont Fabros Technology (DFT) Raised to Outperform at Wachovia.
Level 3 Communications (LVLT) Raised to Hold at Stanford.
Ligand Pharmaceuticals (LGND) Started as Buy at Merriman Curhan Ford.
Northrop Grumman (NOC) Raised to Outperform at Bernstein.
Oxigene (OXGN) Started as Buy at Merriman Curhan Ford.
Pfizer (PFE) Raised to Outperform at Leerink Swann.

Jon C. Ogg
February 12, 2009

“The Next NVIDIA” Could Change Your Life

NVIDIA has returned 250-fold in the past 10 years as artificial intelligence took off.

But if you missed out on NVIDIA’s historic run, your chance to see life-changing profits from AI isn’t over.

The 24/7 Wall Street Analyst who first called NVIDIA’s AI-fueled rise in 2009 just published a brand-new research report named “The Next NVIDIA.”

The report outlines key breakthroughs in AI and the stocks ready to dominate the next wave of growth. The report is absolutely free. Simply enter your email below

Check Your Email! “The Next NVIDIA” Report is Being Sent to Your Inbox Right Now

By providing your email address, you agree to receive communications from us regarding website updates and other offerings that may be of interest to you.
You have the option to opt-out of these emails at any moment. For more information, please review our Disclaimer and Terms of Use.